Omega-3 fatty acids in major depressive disorder: A preliminary double-blind, placebo-controlled trial
- 31 August 2003
- journal article
- clinical trial
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 13 (4), 267-271
- https://doi.org/10.1016/s0924-977x(03)00032-4
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Omega-3 Fatty Acids for Depression in PregnancyAmerican Journal of Psychiatry, 2003
- Randomized, Placebo-Controlled Study of Ethyl-Eicosapentaenoic Acid as Supplemental Treatment in SchizophreniaAmerican Journal of Psychiatry, 2002
- Addition of Omega-3 Fatty Acid to Maintenance Medication Treatment for Recurrent Unipolar Depressive DisorderAmerican Journal of Psychiatry, 2002
- Eicosapentaenoic Acid in Treatment-Resistant DepressionArchives of General Psychiatry, 2002
- A Placebo-Controlled Trial of Omega-3 Fatty Acid (Ethyl Eicosapentaenoic Acid) Supplementation for Residual Symptoms and Cognitive Impairment in SchizophreniaAmerican Journal of Psychiatry, 2001
- Are omega3 Fatty Acids Beneficial in Depression but Not Mania?Archives of General Psychiatry, 2000
- Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis Possible candidate genesProstaglandins, Leukotrienes & Essential Fatty Acids, 1999
- Cross-national epidemiology of major depression and bipolar disorderPublished by American Medical Association (AMA) ,1996
- Fatty acid composition in major depression: decreased ω3 fractions in cholesteryl esters and increased
C 20:4ω6C 20:5ω3Journal of Affective Disorders, 1996 - α‐Linolenic Acid Dietary Deficiency Alters Age‐Related Changes of Dopaminergic and Serotoninergic Neurotransmission in the Rat Frontal CortexJournal of Neurochemistry, 1996